In October, public institutions' research focused on the pharmaceutical and biological sectors.

In October, the enthusiasm of public funds for research has significantly increased. According to data from the Public Fund Ranking Network, a total of 159 public fund institutions participated in research on A-share listed companies in October, covering 632 stocks in 30 industries, with a total of 7452 research visits. This is a significant increase of 60.57% compared to the 4641 visits in September. The breadth and depth of research have also increased simultaneously, laying the groundwork for asset allocation in the fourth quarter, with the healthcare and biotech sector becoming a core focus of institutional attention.